The market for pharmaceutical manufacturing equipment is expanding quickly due to the increasing demand for pharmaceuticals, particularly generic medications. Generic medications provide a cost-effective substitute for brand-name drugs and have...
The Foreign Direct Investment (FDI) equity into the pharmaceutical industry has shown significant growth in the first half of 2024-25, following a 48 percent drop in fiscal 2023-24 compared to the prior year. The quarter from April to September of...
The global pharmaceutical packaging market is consistently expanding due to the demand for more innovative packaging that improves drug effectiveness while integrating sustainable packaging solutions. The Global Pharmaceutical Packaging Market is...
The Indian pharmaceutical market (IPM) saw an increase of 9.9% in value and 3.1% in volume in November, as per Pharmarack. Following a lackluster volume growth for four months, November emerged as a favorable month for the sector, suggesting an...
The expansion of Indian CDMOs and CROs will accelerate because of the generally positive environment. As per Mordor Intelligence, the contract manufacturing sector is expected to double within the next five years, reaching $44.63 billion...
The Indian pharmaceutical market showed a growth of 9.9% year-on-year in November 2024, compared to an average growth of 6.0% year-on-year during the July-October period (which was up 2.9% YoY in November 2023). The overall increase during the...
The medical devices market ranks as the fourth largest in Asia, following Japan, China, and South Korea, and is among the top twenty medical devices markets globally, expanding at a compound annual growth rate (CAGR) of 15 percent. The production...
The rising global demand for weight-loss drugs has propelled major pharmaceuticals firms Eli lilly and Novo Nordisk among the world's most valuable companies as they aggressively compete in the obesity market that analysts predict could cross $100...
The Union government has sanctioned a financial allocation of Rs 15,000 crore for the Production Linked Incentive (PLI) scheme in pharmaceuticals, intended to enhance domestic production. In a written response to Lok Sabha, Union Minister of State...
The arrival of nafithromycin, the nation’s initial homegrown macrolide antibiotic currently waiting for final endorsement from the Central Drugs Standard Control Organization (CDSCO), will mark a crucial moment in the battle against antimicrobial...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")